Skip to content

Schema Therapy for Couples (ST-C) with (one or both having) a Personality Disorder: a pilot study.

Schema Therapy for Couples (ST-C) with (one or both having) a Personality Disorder: a pilot study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24101
Enrollment
12
Registered
2020-09-17
Start date
2020-11-11
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The study is a Multiple Baseline Case Series Study with N = 12 couples. The study has six different baseline lengths: 6, 7, 8, 9, 10 and 11 weeks. In each baseline length there will be 2 couples to
same set up as in condition A), 12 weeks ST-C protocol (including 12 sessions ST-I for the patient, as in condition A), 5 booster sessions (same set up as in condition A).

Sponsors

PsyQ Amsterdam (Parnassia Group)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Personality Disorder according to the criteria of the DSM-5 and as measured using the SCID-5-P - Age 18+ - Ability to understand, read, write and speak Dutch or English

Exclusion criteria

Exclusion criteria: - DSM-5 alcohol or drug dependence. (After 3 months of abstinence participation is possible). - Comorbid psychotic disorder - DSM-5 Bipolar disorder, type 1 (current or past) - Schizo-typical-, Schizoid-, Anti-social PD - Borderline personality disorder patient and or partner - Autism Spectre Disturbance (ASD) - Acute relationship crisis with acute threat of divorce or splitting up - Acute suicide risk - Born with brain damage - Degenerative cognitive disturbances like Alzheimer, Parkinson etc. - IQ < 80 - Schema Therapy of any kind (e.g., individual, group, inpatient, outpatient, day treatment) in the past year. - Patients or their partners should not start with any form of psychological treatment or medication during screening or during the study’s treatment, waitinglist period or till a year after end of last boostersession. Medication should be on a stable level for 3 months, if not stopped. (in case patient and or his partner receives non-PD focused supportive treatment, this can be continued during the waiting period, but not during the study treatment). - Not being able to plan therapy sessions of 60 minutes (ST-C, boostersessions and communication training sessions) and/or 45 minutes (ST-I) within the treatment period. - Moving house plans to outside the agglomeration of Amsterdam. - Partner has PD and wants only to participate in ST-C, refuses to participate in ST-I.

Design outcomes

Primary

MeasureTime frame
Primary outcome will be measured with the Visual Analog Scale (VAS). With the VAS negative (core) beliefs partners have about themselves and each other will be measured on a weekly basis. This will lead to two scores: the average score on negative self beliefs and an average score on negative beliefs about the other.

Secondary

MeasureTime frame
The following scales will be used to measure the secondary outcomes. The ARE (Accessibility, Responsiveness, Emotional Engagement, Conradi et al., 2018) questionnaire measures the security of the attachment bond with the partner. With the Daily Coordination Scale (DC, Finkenauer et al. 2010) one measures the degree to which partners experience their daily interactions as smooth or as difficult.

Contacts

Public ContactLeo Goetstouwers

PsyQ Amsterdam

l.goetstouwers@psyq.nl088 - 35 73 650 / 06-123 77 965

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026